deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT01171170

Paclitaxel-Carboplatin-Bevacizumab +/- Nitroglycerin in Metastatic Non-Squamous-Non-Small Cell Lung Cancer (NVALT12)

A Randomized Phase II Study of Paclitaxel-carboplatin-bevacizumab With or Without Nitroglycerin Patches in Patients With Stage IV Non-squamous-non-small Cell Lung Cancer: NVALT12

Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis

Conditions Non Small Cell Lung Cancer
Interventions Standard treatment plus nitroglycerin carboplatin paclitaxel bevacizumab
Updated 7 times since 2017 Last updated: Sep 24, 2020 Started: Jan 31, 2011 Primary completion: Jun 30, 2014 Completion: Aug 31, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Non Small Cell Lung Cancer and is currently completed. Dutch Society of Physicians for Pulmonology and Tuberculosis leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Oct 2020 · 28 months · monthly snapshotUnknown Status~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Oct 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

▶ Show 2 earlier versions

  1. Jun 2018 — Oct 2020 [monthly]

    Unknown Status PHASE2

  2. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

    First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dutch Society of Physicians for Pulmonology and Tuberculosis
Data source: Dutch Society of Physicians for Pulmonology and Tuberculosis

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations